Pfizer Exec Urges National People’s Congress To Adopt Diversified Funding Mechanism For Biologics, Targeted Cancer Therapies

Pfizer Inc.’s China Corporate Affairs Director Danlong Feng is the first executive from a multinational firm in China to serve as a delegate at the annual Chinese People’s Political Consultative Conference. Feng called on government, drug makers and insurers to create diversified funding mechanisms to widen access to innovative therapies in China.